Paul T. Finger, MD, FACS
The New York Eye Cancer Center
Director
115 East 61st Street
5th Floor
5A
New York, NY 10021
United States map
(212) 832-8170 office
(212) 888-4030 fax
Professional Affiliations
Academic Appointments- Clinical Professor of Ophthalmology
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Health System
- Lenox Hill / Manhattan Eye, Ear and Throat Hospital
Biography
Paul T. Finger, M.D., specializes in Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy.
Select Innovations/Discoveries:
Intravitreal Anti-VEGF Therapy for Radiation Retinopathy
Intravitreal Anti-VEGF Therapy for Radiation Optic Neuropathy
Yttrium-90 HDR episcleral ophthalmic plaque radiation therapy
Palladium-103 ophthalmic plaque therapy
Topical Mitomycin and Interferon for Conjunctival Melanoma
Aspiration Cutter assisted anterior segment tumor biopsy (FIT)
Aspiration Cutter assisted orbital tumor biopsy (FACT)
Most Recent Innovation:
Most recently he has developed the first light-guided, light defined, episcleral high-dose-rate beta radiation technique. Here lights surround and thereby define the posterior treatment zone as viewed through the pupil (see https://journals.sagepub.com/doi/10.1177/24741264241227684)
To make these FDA-cleared Y-90 applicators available for retinal vascular growths, he built the company Liberty Vision Corporation (https:\\libertyvision.com)
Paul T. Finger, M.D. is a Fellow of both the American Academy of Ophthalmology and the American College of Surgeons. He is Chair of the Ophthalmic Oncology Task Force (OOTF), which created the worlds' eye cancer staging systems for the American Joint Committee on Cancer - International Union for Cancer Care (AJCC -UICC). He directed the OOTF to create consensus guidelines for the American Brachytherapy Society (ABS) and AAPM. He wrote and edited his recent textbook "Finger's Essential Ophthalmic Oncology." In addition, he has published over 300 peer-reviewed scientific articles and greater-than 50 book chapters . Chapters include those in DeVita's Cancer and Ryan's Retina.